Search

everythinglearnresearchcommunity

for

Search:↓

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Somatostatin may help protect hair follicles from immune attacks.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Baricitinib successfully treated severe hair loss.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

OR-101 shows promise for treating alopecia areata by improving hair growth.

JAK inhibitors might help treat alopecia areata.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Statins may help treat alopecia areata by reducing harmful immune interactions.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Apremilast may help treat hair loss in alopecia areata.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.